Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Whitty

Showing results (121-130 of 211) with videos related to

Pageof 22
Sort By:
Australian Health Review : a Publication of the Australian Hospital Association|August 8, 2014
Chronic conditions, financial burden and pharmaceutical pricing: insights from Australian consumersJennifer A Whitty, Adem Sav, Fiona Kelly, et al.
Research in Social & Administrative Pharmacy : RSAP|December 11, 2012
Community pharmacy in Australia: a health hub destination of the futureSara S McMillan, Amanda J Wheeler, Adem Sav, et al.
The Patient|May 5, 2016
Treatment Burden and Chronic Illness: Who is at Most Risk?Adem Sav, Jennifer A Whitty, Sara S McMillan, et al.
BMC Public Health|March 16, 2016
Study protocol: developing a decision system for inclusive housing: applying a systematic, mixed-method quasi-experimental designHeidi Zeeman, Elizabeth Kendall, Jennifer A Whitty, et al.
BMJ Open|May 6, 2014
Engaging the public in healthcare decision-making: quantifying preferences for healthcare through citizens' juriesPaul A Scuffham, Julie Ratcliffe, Elizabeth Kendall, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1989
Potential antiinflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor alpha, interleukin 1, and prostaglandin E2P H Hart, G F Vitti, D R Burgess, et al.
Head & Neck|September 19, 2012
Economic analysis of FDG-PET-guided management of the neck after primary chemoradiotherapy for node-positive head and neck squamous cell carcinomaDavid I Pryor, Sandro V Porceddu, Paul A Scuffham, et al.
The Patient|December 17, 2014
Consumers and Carers Versus Pharmacy Staff: Do Their Priorities for Australian Pharmacy Services Align?Sara S McMillan, Fiona Kelly, Adem Sav, et al.
BMC Health Services Research|December 16, 2015
The ideal healthcare: priorities of people with chronic conditions and their carersAdem Sav, Sara S McMillan, Fiona Kelly, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 24, 2012
National drug policies to local formulary decisions in Thailand, China, and Australia: drug listing changes and opportunitiesWorasuda Yoongthong, Shanlian Hu, Jennifer A Whitty, et al.
Pageof 22

Showing results (121-130 of 211) with videos related to

Sort By:
Pageof 22
Australian Health Review : a Publication of the Australian Hospital Association|August 8, 2014
Chronic conditions, financial burden and pharmaceutical pricing: insights from Australian consumersJennifer A Whitty, Adem Sav, Fiona Kelly, et al.
Research in Social & Administrative Pharmacy : RSAP|December 11, 2012
Community pharmacy in Australia: a health hub destination of the futureSara S McMillan, Amanda J Wheeler, Adem Sav, et al.
The Patient|May 5, 2016
Treatment Burden and Chronic Illness: Who is at Most Risk?Adem Sav, Jennifer A Whitty, Sara S McMillan, et al.
BMC Public Health|March 16, 2016
Study protocol: developing a decision system for inclusive housing: applying a systematic, mixed-method quasi-experimental designHeidi Zeeman, Elizabeth Kendall, Jennifer A Whitty, et al.
BMJ Open|May 6, 2014
Engaging the public in healthcare decision-making: quantifying preferences for healthcare through citizens' juriesPaul A Scuffham, Julie Ratcliffe, Elizabeth Kendall, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1989
Potential antiinflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor alpha, interleukin 1, and prostaglandin E2P H Hart, G F Vitti, D R Burgess, et al.
Head & Neck|September 19, 2012
Economic analysis of FDG-PET-guided management of the neck after primary chemoradiotherapy for node-positive head and neck squamous cell carcinomaDavid I Pryor, Sandro V Porceddu, Paul A Scuffham, et al.
The Patient|December 17, 2014
Consumers and Carers Versus Pharmacy Staff: Do Their Priorities for Australian Pharmacy Services Align?Sara S McMillan, Fiona Kelly, Adem Sav, et al.
BMC Health Services Research|December 16, 2015
The ideal healthcare: priorities of people with chronic conditions and their carersAdem Sav, Sara S McMillan, Fiona Kelly, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 24, 2012
National drug policies to local formulary decisions in Thailand, China, and Australia: drug listing changes and opportunitiesWorasuda Yoongthong, Shanlian Hu, Jennifer A Whitty, et al.
Pageof 22